Martin Rudwaleit

Head

Bielefeld University

Germany

Research Interests

Explore related searches

Professors in Germany Professors in Immunology Immunology professors in Germany

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Martin Rudwaleit is the Head at Klinikum Bielefeld, Germany. His research areas include axial spondyloarthritis, specifically focusing on radiographic structural damage, disease activity over time, and the clinical outcomes of various treatments. He has contributed to understanding the role of HLA-B27 and the inflammatory response in spondyloarthritis through recent publications.

Articles (10)

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Collaborators (3)

Vincent Goeb

Professor of Rheumatology, Head of Department

Université de Picardie Jules Verne

FRANCE

View details

Matthew A Brown

Chief Scientific Officer

NHS England

UNITED KINGDOM

View details

Floris van Gaalen

Leiden University Medical Center

NETHERLANDS

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Martin Rudwaleit

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Response to the correspondence on “Radiographic structural damage in axial spondyloarthritis: is there a preferred way to quantify progression over time?”

Longitudinal association of early axial spondyloarthritis status at the time of diagnosis with disease activity over time: 10-year results from the GESPIC cohort

BASDAI and ASDAS disease states in relationship to ASAS40 response: post hoc analysis of ixekizumab in radiographic axial spondyloarthritis

Low uveitis rates in patients with axial spondyloarthritis treated with bimekizumab: pooled results from phase 2b/3 trials

HLA-B27 and the role of specific T cell receptors in the pathogenesis of spondyloarthritis

Comparison of established and preliminarily proposed ASAS MRI working group cut-offs for inflammatory MRI lesions in the sacroiliac joints in radiographic and non-radiographic axial spondyloarthritis

Exploratory analysis of the potential disconnect between objective inflammatory response and clinical response following certolizumab pegol treatment in patients with active axial spondyloarthritis

Long-term clinical outcomes of certolizumab pegol treatment in non-radiographic axial spondyloarthritis stratified by baseline MRI and CRP status

Association of clinical response criteria and disease activity levels with axial spondyloarthritis core domains: results from two phase 3 randomised studies, BE MOBILE 1 and 2

Work productivity in patients with axial spondyloarthritis initiating biological or targeted synthetic disease-modifying antirheumatic drugs: a systematic literature review and meta-analysis

Collaborators (3)

Vincent Goeb

Matthew A Brown

Floris van Gaalen

Make your next move.